■大部分语音都表达了,表现出具有基本频率和许多较高态度的一定程度。一些神经种群对这种时间良好的结构做出反应,特别是在基本频率下。This frequency-following response to speech consists of both sub- cortical and cortical contributions and can be measured through EEG as well as through magnetoencephalography (MEG), although both differ in the aspects of neural activity that they capture: EEG is sensitive to both radial and tangential sources as well as to deep sources, whereas MEG is more restrained to the measurement of tangential and superficial neural activity.eeg对连续语音的反应显示,与
15。继承(a)将基因定义为遗传单位,并清楚地区分术语基因和等位基因(b)解释了术语的主导性,隐性,隐性,纯合,纯合,纯合,合成性,表型,表型和基因型和基因型(c)与3:1和1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1: (d) explain why observed ratios often differ from expected ratios, especially when there are small numbers of progeny (e) use genetic diagrams to solve problems involving monohybrid inheritance (genetic diagrams involving autosomal linkage or epistasis are not required) (f) explain co-dominance and multiple alleles with reference to the inheritance of the ABO blood group phenotypes (A, B, AB and O) and the gene等位基因(i a,i b和o)(g)描述人类性别的确定 - XX和XY染色体(H)将突变描述为基因结构的变化,例如在镰状细胞贫血中或染色体数字中,例如在诸如47个染色体的染色体数字中,该状态为47个染色体。
前瞻性陈述不能保证未来的绩效。相反,它们基于当前的观点和假设,涉及已知和未知的风险,不确定性和其他因素,其中许多因素很难预测和/或不在公司的控制之外。If any of these risks and uncertainties materialize (or they occur with a degree of severity beyond the Company's predictions and/or expectations) or other assumptions underlying any of the forward-looking statements prove to be incorrect, the actual results or developments may differ materially from any future results or developments expressed or implied by the forward-looking statements, which are sometimes based upon estimates and data received from third parties (such estimates and data being often 修改)。除非适用规则另有规定,Iveco Group明确否认本演示文稿中提供,更新或修改任何前瞻性陈述的任何意图,以反映期望的任何变化或这些前瞻性陈述所基于的事件,条件,条件或情况的任何变化。Iveco集团或代表其行为的人的所有前瞻性陈述都明确地由本文包含的警示陈述全部符合资格。
前瞻性陈述:本版本中的某些陈述可能包括1995年《私人证券诉讼改革法》的含义,包括不受限制的陈述,关于雇用销售人员和扩展我们的分销渠道的影响的陈述。前瞻性陈述是基于当前期望和假设的预测,预测和其他关于未来事件的陈述,因此,风险和不确定性都受到风险和不确定性的影响。Many factors could cause actual future events to differ materially from the forward-looking statements in this release, including, without limitation, those risk associated with our post-market clinical data collection activities, benefits of our products to patients, our expectations with respect to product development and commercialization efforts, our ability to increase market and physician acceptance of our products, potentially competitive product offerings, intellectual property protection, FDA regulatory actions, our ability to integrate acquired businesses, our expectations regarding预期的协同效应和收益的福利,以及我们提交给SEC的文件中描述的其他风险和不确定性。前瞻性陈述仅是制作日期的说法。daxor不承担任何义务公开更新或修改任何前瞻性陈述,无论是由于新信息,未来事件还是其他方式。本演示文稿不构成出售或征求购买任何安全性的要约。
本新闻稿包含联邦证券法的含义中的前瞻性陈述,包括但不限于以下陈述:我们2025财政年度,2026财政年度以及长期,销售增长和非GAAP模型和相关的假设,包括我们在资本分配的计划,包括股票回购和市场份额和市场份额和商业机会和市场趋势,以及我们的资本分配计划。A detailed discussion of these and other risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in Logitech's periodic filings with the Securities and Exchange Commission (SEC), including our Annual Report on Form 10-K for the fiscal year ended March 31, 2024, our Quarterly Report on Form 10-Q for the quarter ended December 31, 2024, and other reports filed with the SEC, available at www.sec.gov,标题为风险因素和其他地方。Logitech不承担任何义务来更新任何前瞻性语句,以反映本新闻稿日期之后发生的新信息或事件或情况。请注意,除非另有说明,否则比较是一年一度的。Logitech和其他Logitech标记是Logitech Europe S.A和/或其在美国和其他国家/地区的分支机构的商标或注册商标。所有其他商标都是其各自所有者的财产。有关Logitech及其产品的更多信息,请访问公司的网站www.logitech.com。(logiir)
本演示文稿包含联邦证券法所定义的前瞻性陈述。实际结果可能与此类前瞻性陈述存在重大差异。可能导致实际结果不同的因素在本文附录和 NextEra Energy 的 SEC 文件中进行了讨论。
本文件可能包含前瞻性陈述,需要注意的是,未来结果可能与讨论的结果存在重大差异。有关可能导致未来结果存在重大差异的因素的完整讨论,请参阅爱达荷电力提交给美国证券交易委员会的文件。
本演示文稿包含联邦证券法所定义的前瞻性陈述。实际结果可能与此类前瞻性陈述存在重大差异。可能导致实际结果不同的因素在本文附录和 NextEra Energy 的 SEC 文件中进行了讨论。
这些演示文稿包括联邦证券法的含义中的前瞻性陈述。实际结果可能与此类前瞻性陈述有实质性不同。在本文和Nextera Energy Partners的SEC申请中讨论了可能导致实际结果不同的因素。非GAAP财务信息
本演示文稿包含有关布里斯托尔美犬公司(“公司”)未来财务业绩,计划,业务发展策略,预期临床试验,结果和监管部门批准的陈述,这些临床试验,结果和监管部门构成了前瞻性陈述,构成了《安全港规定》,《私人证券诉讼改革法案》,1995年的《私人证券诉讼改革法》。所有不是历史事实陈述的陈述都是或可能被认为是前瞻性陈述。Actual results may differ materially from those expressed in, or implied by, these statements as a result of various factors, including, but not limited to, (i) new laws and regulations, (ii) our ability to obtain, protect, and maintain market exclusivity rights and enforce patents and other intellectual property rights, (iii) our ability to achieve expected clinical, regulatory and contractual milestones on expected timelines or at all, (iv) difficulties or delays in the development以及新产品的商业化,(v)在我们的临床试验以及产品的制造,分销和销售中的困难或延迟,(vi)法律或监管程序中的不利结果,(VII)风险与收购,划分,联盟,联盟,合资风险,合资企业和其他投资组合行动以及(VIII和财务状况)的风险有关这些和其他重要因素在公司的最新年度报告中进行了10-K的最新报告,以及有关表格10-Q和8-K的报告。这些文件可在美国证券交易委员会的网站,公司的网站或Bristol-Myers Squibb投资者关系中找到。无法保证前瞻性语句。